Yahoo
OTC Markets OTCPK - Delayed Quote USD

IMAC Holdings, Inc. (BACK)

0.0001 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for BACK
  • Previous Close 0.0001
  • Open 0.0002
  • Bid 0.0160 x 4939000
  • Ask 0.0290 x 3945000
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0001 - 0.2100
  • Volume 200
  • Avg. Volume 3,078
  • Market Cap (intraday) 378
  • Beta (5Y Monthly) 2.20
  • PE Ratio (TTM) --
  • EPS (TTM) -3.5000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.

imacregeneration.gcs-web.com

15

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BACK
99.93%
S&P 500 (^GSPC)
7.76%

1-Year Return

BACK
99.84%
S&P 500 (^GSPC)
9.77%

3-Year Return

BACK
99.99%
S&P 500 (^GSPC)
68.96%

5-Year Return

BACK
100.00%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY24
Revenue --
Earnings -407.22k
Profit Margin 0.00%

Q2

FY23

Q3

FY23

Q4

FY23

Q1

FY24

-2M
-1M
0
1M
-600.0%
-400.0%
-200.0%
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -550.66%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    22.72k

  • Net Income Avi to Common (ttm)

    -14.7M

  • Diluted EPS (ttm)

    -3.5000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.05k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -606.81k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: